Drug Shortage Report for BREVIBLOC PREMIXED INJECTION
Report ID | 91707 |
Drug Identification Number | 02309238 |
Brand name | BREVIBLOC PREMIXED INJECTION |
Common or Proper name | BREVIBLOC PREMIXED INJECTION |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | ESMOLOL HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 250 mL Intravia Container |
ATC code | C07AB |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-08-16 |
Actual start date | 2019-08-16 |
Estimated end date | 2019-09-16 |
Actual end date | 2019-09-16 |
Shortage status | Resolved |
Updated date | 2019-09-17 |
Company comments | Very limited stock. Product on allocation. We have Brevibloc 10mg/mL VIALS available which can be reconstituted as per the customer requirement. For questions or concerns contact Baxter customer care (1.888.719.9955) or your local representative. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2019-09-17 | English | Compare |
v9 | 2019-09-16 | French | Compare |
v8 | 2019-09-16 | English | Compare |
v7 | 2019-09-12 | French | Compare |
v6 | 2019-09-12 | English | Compare |
v5 | 2019-08-28 | French | Compare |
v4 | 2019-08-28 | English | Compare |
v3 | 2019-08-17 | English | Compare |
v2 | 2019-08-16 | French | Compare |
v1 | 2019-08-16 | English | Compare |
Showing 1 to 10 of 10